Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

Reducing the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is the key ultimate goal set in essentially all treatment guidelines. There has been solid evidence supporting the relationship between serum hepatitis B virus (HBV) DNA level and risk of HCC. Antivir...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Gastroenterol
मुख्य लेखकों: Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Wong, Grace Lai-Hung
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Singapore 2020
विषय:
Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7567686/
https://ncbi.nlm.nih.gov/pubmed/32974760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01726-3
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन